🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

After closing a $60M Series A financing led by Madrona, today we officially launched Terray Therapeutics – a #biotech with the chemistry engine and #AI to propel #drugdiscovery into the information age. Learn more here: terraytx.com #biotechnews

Excited to announce our investment in Terray Therapeutics today! Read more from Chris Picardo on this Intersections of Innovation company and why invested. madrona.com/intersections-…

tNova is our #AI-driven drug discovery platform that operates at an unrivaled scale, using #MachineLearning to become increasingly precise with each cycle of virtual molecular design and measurement. This is the chemistry engine that puts transformative therapeutics within reach.

Terray is thrilled to welcome Feroze (Fez) Ujjainwalla as Head of Business and Adam D. Hughes as Head of Chemistry. Read more about how Fez and Adam will bolster Terray's world-class management team: terraytx.com

We're honored to support an extraordinary cause!

Terray is proud to announce a multi-target collaboration with Calico. The Terray and Calico teams will work together to discover and develop small molecule therapeutics for diseases of aging, including cancer. Read more here: prnewswire.com/news-releases/…

We are pleased to announce a new collaboration with Terray Therapeutics focused on the discovery and development of novel small molecule therapeutics for diseases of #aging, including #cancer. To learn more: bit.ly/3VnQvLM

NVentures backed Terray Therapeutics, has unveiled COATI-LDM—a groundbreaking #genAI model for designing small molecules with precision. This innovative example of inverse design has potential to greatly accelerate #drugdiscovery. Check out the arXiv preprint nvda.ws/3MhwqDF